يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"human epidermal growth factor receptor 2"', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 1

    المصدر: Breast, Vol 59, Iss, Pp 144-156 (2021)
    The Breast : Official Journal of the European Society of Mastology

  2. 2

    المصدر: EBioMedicine
    EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, MBC, metastatic breast cancer, ER, estrogen receptor, Receptor, ErbB-2, Gene mutation pattern, Estrogen receptor, lcsh:Medicine, Drug resistance, SNV, Single nucleotide variants, Gene mutation, medicine.disease_cause, Circulating Tumor DNA, SEER, Surveillance Epidemiology and End Results, AUC, area under the curve, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, Indels, insertions and deletions, Neoplasm Metastasis, skin and connective tissue diseases, Triple-negative breast cancer, TNBC, triple negative breast cancer, Mutation, lcsh:R5-920, Mediator Complex, BRCA1 Protein, Progression-free survival, General Medicine, Middle Aged, Metastatic breast cancer, PFS, progression-free survival, Drug Resistance, Multiple, Gene Expression Regulation, Neoplastic, GX, gemcitabine+capecitabine, 030220 oncology & carcinogenesis, Disease Progression, Female, lcsh:Medicine (General), Circulating tumor DNA (ctDNA), WES, whole exome sequencing, IHC, immunohistochemistry, Research Paper, Adult, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Biomarkers, Tumor, Humans, neoplasms, AI, aromatase inhibitor, Aged, HR/HER2 subtype, TMB, Tumor mutation burden, business.industry, lcsh:R, Cancer, HR, hormone receptor, PR, progesterone receptor, cfDNA, cell-free DNA, medicine.disease, HR, hazard ratio, ROC, receiver operating characteristic, CI, confidence interval, 030104 developmental biology, Drug Resistance, Neoplasm, gDNA, genomic DNA, Tumor Suppressor Protein p53, business